Efficacy and safety of linagliptin according to patient baseline characteristics: A pooled analysis of three phase 3 trials

We aimed to determine if patient baseline characteristics affect responses to linagliptin and identify relevant predictors of glycated hemoglobin (HbA1c) reduction in patients with type 2 diabetes mellitus (T2DM).

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - June 30, 2016 Category: Nutrition Authors: S. Del Prato, S. Patel, S. Crowe, M. von Eynatten Source Type: research